Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals, Inc - Common Stock (NQ: ADIL )

1.050 +0.020 (+1.94%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Adial Pharmaceuticals, Inc - Common Stock

MicroCap Rodeo’s Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies
Via ACCESSWIRE
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Thursday Morning’s Most Active Stocks
Via Investor Brand Network
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is One of Friday Morning’s Most Active Stocks
Via Investor Brand Network
Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20
Via ACCESSWIRE
Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th
Via ACCESSWIRE
Adial Pharmaceuticals to Present at Microcap Rodeo's Fall Harvest - Best Ideas from the Buy-Side on Tuesday, October 5, 2021
CHARLOTTESVILLE, VA / ACCESSWIRE / October 5, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing... 
From Adial Pharmaceuticals, Inc.
Via AccessWire
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be... 
From MicroCap Rodeo
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.